James Investment Research Inc. Has $1.06 Million Stake in Tenet Healthcare Corp (NYSE:THC)

James Investment Research Inc. cut its stake in shares of Tenet Healthcare Corp (NYSE:THC) by 48.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 36,787 shares of the company’s stock after selling 34,669 shares during the period. James Investment Research Inc.’s holdings in Tenet Healthcare were worth $1,061,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in THC. Retirement Systems of Alabama lifted its stake in Tenet Healthcare by 0.6% during the 1st quarter. Retirement Systems of Alabama now owns 108,254 shares of the company’s stock valued at $3,122,000 after acquiring an additional 611 shares during the period. GWM Advisors LLC purchased a new stake in shares of Tenet Healthcare during the fourth quarter worth $201,000. GSA Capital Partners LLP boosted its position in shares of Tenet Healthcare by 925.8% during the 4th quarter. GSA Capital Partners LLP now owns 85,951 shares of the company’s stock valued at $1,473,000 after acquiring an additional 77,572 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of Tenet Healthcare by 110.4% during the 3rd quarter. AQR Capital Management LLC now owns 668,309 shares of the company’s stock valued at $19,020,000 after acquiring an additional 350,745 shares during the last quarter. Finally, Flinton Capital Management LLC boosted its position in shares of Tenet Healthcare by 3.6% during the 4th quarter. Flinton Capital Management LLC now owns 14,484 shares of the company’s stock valued at $248,000 after acquiring an additional 510 shares during the last quarter.

Tenet Healthcare stock traded down $0.01 during midday trading on Wednesday, reaching $22.86. The company’s stock had a trading volume of 1,594,500 shares, compared to its average volume of 1,535,409. The company has a market cap of $2.27 billion, a P/E ratio of 12.29, a price-to-earnings-growth ratio of 0.39 and a beta of 1.68. Tenet Healthcare Corp has a fifty-two week low of $16.60 and a fifty-two week high of $39.74. The company has a debt-to-equity ratio of 21.98, a quick ratio of 1.15 and a current ratio of 1.23.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Monday, April 29th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.29 by $0.25. The company had revenue of $4.55 billion during the quarter, compared to analysts’ expectations of $4.51 billion. Tenet Healthcare had a positive return on equity of 29.29% and a negative net margin of 0.04%. The firm’s revenue was down 3.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.57 EPS. Sell-side analysts predict that Tenet Healthcare Corp will post 2.32 EPS for the current year.

A number of research analysts have commented on THC shares. Mizuho reaffirmed a “buy” rating and issued a $28.00 target price on shares of Tenet Healthcare in a research report on Monday, January 28th. Raymond James upped their target price on shares of Tenet Healthcare from $37.00 to $47.00 in a research note on Wednesday, February 27th. Citigroup increased their price target on shares of Tenet Healthcare from $35.00 to $37.00 and gave the company a “buy” rating in a research note on Wednesday, February 27th. Bank of America reiterated a “neutral” rating and issued a $30.00 price target (up from $21.00) on shares of Tenet Healthcare in a research note on Tuesday, February 26th. Finally, Barclays set a $24.00 price target on shares of Tenet Healthcare and gave the company a “hold” rating in a research note on Wednesday, April 17th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. Tenet Healthcare presently has an average rating of “Hold” and a consensus price target of $30.07.

TRADEMARK VIOLATION WARNING: This piece of content was originally posted by Sundance Herald and is owned by of Sundance Herald. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://sundanceherald.com/2019/05/22/james-investment-research-inc-reduces-position-in-tenet-healthcare-corp-thc.html.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Featured Story: What does a bar chart display?

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply